| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 65,518 | 65,518 |
| Effect of exchange rate changes on cash and cash equivalents | 621 | 592 |
| Net change in cash and cash equivalents | -536 | 19,642 |
| Cash and cash equivalents at beginning of period | 35,668 | - |
| Cash and cash equivalents at end of period | 35,132 | - |
IMMUNIC, INC. (IMUX)
IMMUNIC, INC. (IMUX)